Your browser doesn't support javascript.
loading
Late hepatitis B reactivation following direct-acting antiviral-based treatment of recurrent hepatitis C in an anti-HBc-positive liver transplant recipient.
Vionnet, Julien; Pascual, Manuel; Testoni, Barbara; Combet, Christophe; Godat, Sébastien; Vijgen, Sandrine; Aubert, Vincent; Rubbia-Brandt, Laura; Zoulim, Fabien; Moradpour, Darius.
Afiliación
  • Vionnet J; Transplantation Center, Lausanne, Switzerland.
  • Pascual M; Service of Gastroenterology and Hepatology as well as, Lausanne, Switzerland.
  • Testoni B; Transplantation Center, Lausanne, Switzerland.
  • Combet C; INSERM U1052, Cancer Research Center of Lyon, University of Lyon, Lyon, France.
  • Godat S; INSERM U1052, Cancer Research Center of Lyon, University of Lyon, Lyon, France.
  • Vijgen S; Service of Gastroenterology and Hepatology as well as, Lausanne, Switzerland.
  • Aubert V; Service of Clinical Pathology, University Hospital of Geneva, University of Geneva, Geneva, Switzerland.
  • Rubbia-Brandt L; Service of Immunology and Allergy, University Hospital of Lausanne, Lausanne, Switzerland.
  • Zoulim F; Service of Clinical Pathology, University Hospital of Geneva, University of Geneva, Geneva, Switzerland.
  • Moradpour D; INSERM U1052, Cancer Research Center of Lyon, University of Lyon, Lyon, France.
Hepatology ; 67(2): 791-793, 2018 02.
Article en En | MEDLINE | ID: mdl-28921620
ABSTRACT
Direct-acting antivirals (DAAs) have changed the landscape of hepatitis C virus (HCV) treatment, but chronic hepatitis C (CHC) remains a leading indication for liver transplantation (LT). Hepatitis B virus (HBV) reactivation has been reported in HBV-HCV-coinfected patients treated with DAAs. We report on a case of late HBV reactivation after DAA-based treatment of recurrent hepatitis C in an antibody against hepatitis B core antigen (anti-HBc)-positive LT recipient. (Hepatology 2018;67791-793).
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Activación Viral / Virus de la Hepatitis B / Trasplante de Hígado / Hepatitis C Crónica / Anticuerpos contra la Hepatitis B / Antígenos del Núcleo de la Hepatitis B Límite: Humans / Male / Middle aged Idioma: En Revista: Hepatology Año: 2018 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Activación Viral / Virus de la Hepatitis B / Trasplante de Hígado / Hepatitis C Crónica / Anticuerpos contra la Hepatitis B / Antígenos del Núcleo de la Hepatitis B Límite: Humans / Male / Middle aged Idioma: En Revista: Hepatology Año: 2018 Tipo del documento: Article País de afiliación: Suiza